vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and SPX Technologies, Inc. (SPXC). Click either name above to swap in a different company.

SPX Technologies, Inc. is the larger business by last-quarter revenue ($566.8M vs $336.6M, roughly 1.7× Guardian Pharmacy Services, Inc.). SPX Technologies, Inc. runs the higher net margin — 10.6% vs 4.0%, a 6.5% gap on every dollar of revenue. On growth, SPX Technologies, Inc. posted the faster year-over-year revenue change (22.0% vs 2.2%).

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

SPX Technologies, Inc. is an American manufacturing company, headquartered in Charlotte, North Carolina. The company operates within four markets: heating, ventilation, and air conditioning (HVAC), detection and measurement, power transmission and generation, and engineered solutions. Examples of SPX’s products include cooling towers and boilers, underground pipe and cable locators, power transformers, and heat exchangers. Brands include Waukesha, Dielectric, Genfare, Fahrenheat, Radiodetecti...

GRDN vs SPXC — Head-to-Head

Bigger by revenue
SPXC
SPXC
1.7× larger
SPXC
$566.8M
$336.6M
GRDN
Growing faster (revenue YoY)
SPXC
SPXC
+19.8% gap
SPXC
22.0%
2.2%
GRDN
Higher net margin
SPXC
SPXC
6.5% more per $
SPXC
10.6%
4.0%
GRDN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GRDN
GRDN
SPXC
SPXC
Revenue
$336.6M
$566.8M
Net Profit
$13.5M
$59.9M
Gross Margin
22.7%
Operating Margin
5.3%
15.5%
Net Margin
4.0%
10.6%
Revenue YoY
2.2%
22.0%
Net Profit YoY
46.1%
17.0%
EPS (diluted)
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
SPXC
SPXC
Q1 26
$336.6M
$566.8M
Q4 25
$397.6M
$637.3M
Q3 25
$377.4M
$592.8M
Q2 25
$344.3M
$552.4M
Q1 25
$329.3M
$482.6M
Q4 24
$533.7M
Q3 24
$314.4M
$483.7M
Q2 24
$501.3M
Net Profit
GRDN
GRDN
SPXC
SPXC
Q1 26
$13.5M
$59.9M
Q4 25
$20.9M
$77.9M
Q3 25
$9.8M
$62.7M
Q2 25
$9.0M
$52.2M
Q1 25
$9.4M
$51.2M
Q4 24
$57.1M
Q3 24
$-122.0M
$50.2M
Q2 24
$44.2M
Gross Margin
GRDN
GRDN
SPXC
SPXC
Q1 26
22.7%
Q4 25
21.5%
39.8%
Q3 25
19.8%
40.4%
Q2 25
19.8%
41.4%
Q1 25
19.5%
40.6%
Q4 24
40.9%
Q3 24
19.4%
40.9%
Q2 24
40.1%
Operating Margin
GRDN
GRDN
SPXC
SPXC
Q1 26
5.3%
15.5%
Q4 25
7.7%
15.7%
Q3 25
4.3%
16.4%
Q2 25
3.7%
15.7%
Q1 25
3.9%
13.8%
Q4 24
16.9%
Q3 24
-33.3%
16.3%
Q2 24
14.9%
Net Margin
GRDN
GRDN
SPXC
SPXC
Q1 26
4.0%
10.6%
Q4 25
5.3%
12.2%
Q3 25
2.6%
10.6%
Q2 25
2.6%
9.4%
Q1 25
2.9%
10.6%
Q4 24
10.7%
Q3 24
-38.8%
10.4%
Q2 24
8.8%
EPS (diluted)
GRDN
GRDN
SPXC
SPXC
Q1 26
$0.21
Q4 25
$1.56
Q3 25
$1.28
Q2 25
$1.10
Q1 25
$1.09
Q4 24
$1.21
Q3 24
$1.06
Q2 24
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
SPXC
SPXC
Cash + ST InvestmentsLiquidity on hand
$64.9M
$156.5M
Total DebtLower is stronger
$667.3M
Stockholders' EquityBook value
$232.4M
$2.3B
Total Assets
$426.9M
$3.9B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
SPXC
SPXC
Q1 26
$64.9M
$156.5M
Q4 25
$65.6M
$364.0M
Q3 25
$36.5M
$229.4M
Q2 25
$18.8M
$132.8M
Q1 25
$14.0M
$177.8M
Q4 24
$156.9M
Q3 24
$37.2M
$124.8M
Q2 24
$128.1M
Total Debt
GRDN
GRDN
SPXC
SPXC
Q1 26
$667.3M
Q4 25
$0
$496.7M
Q3 25
$499.8M
Q2 25
$950.3M
Q1 25
$872.0M
Q4 24
$577.0M
Q3 24
$34.3M
$665.2M
Q2 24
$509.9M
Stockholders' Equity
GRDN
GRDN
SPXC
SPXC
Q1 26
$232.4M
$2.3B
Q4 25
$217.9M
$2.2B
Q3 25
$195.5M
$2.1B
Q2 25
$179.7M
$1.5B
Q1 25
$163.2M
$1.4B
Q4 24
$1.4B
Q3 24
$133.9M
$1.4B
Q2 24
$1.3B
Total Assets
GRDN
GRDN
SPXC
SPXC
Q1 26
$426.9M
$3.9B
Q4 25
$412.7M
$3.6B
Q3 25
$390.0M
$3.4B
Q2 25
$356.3M
$3.3B
Q1 25
$334.0M
$3.1B
Q4 24
$2.7B
Q3 24
$348.0M
$2.8B
Q2 24
$2.8B
Debt / Equity
GRDN
GRDN
SPXC
SPXC
Q1 26
0.29×
Q4 25
0.00×
0.22×
Q3 25
0.23×
Q2 25
0.62×
Q1 25
0.60×
Q4 24
0.42×
Q3 24
0.26×
0.49×
Q2 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
SPXC
SPXC
Operating Cash FlowLast quarter
$6.1M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
2.0%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
0.45×
TTM Free Cash FlowTrailing 4 quarters
$268.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
SPXC
SPXC
Q1 26
$6.1M
Q4 25
$34.6M
$195.2M
Q3 25
$28.2M
$106.5M
Q2 25
$19.9M
$42.5M
Q1 25
$17.6M
$-10.9M
Q4 24
$166.5M
Q3 24
$51.4M
Q2 24
$57.5M
Free Cash Flow
GRDN
GRDN
SPXC
SPXC
Q1 26
$11.3M
Q4 25
$126.7M
Q3 25
$24.2M
$96.1M
Q2 25
$34.8M
Q1 25
$-16.4M
Q4 24
$156.7M
Q3 24
$43.5M
Q2 24
$47.1M
FCF Margin
GRDN
GRDN
SPXC
SPXC
Q1 26
2.0%
Q4 25
19.9%
Q3 25
6.4%
16.2%
Q2 25
6.3%
Q1 25
-3.4%
Q4 24
29.4%
Q3 24
9.0%
Q2 24
9.4%
Capex Intensity
GRDN
GRDN
SPXC
SPXC
Q1 26
3.3%
Q4 25
10.7%
Q3 25
1.1%
1.8%
Q2 25
1.4%
Q1 25
1.1%
Q4 24
1.8%
Q3 24
1.6%
Q2 24
2.1%
Cash Conversion
GRDN
GRDN
SPXC
SPXC
Q1 26
0.45×
Q4 25
1.65×
2.51×
Q3 25
2.87×
1.70×
Q2 25
2.21×
0.81×
Q1 25
1.86×
-0.21×
Q4 24
2.92×
Q3 24
1.02×
Q2 24
1.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons